ICON Awarded Best CRO at World Vaccine Congress 2017 Read more about ICON Awarded Best CRO at World Vaccine Congress 2017
ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials Read more about ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials
ICON Reports Fourth Quarter and Full Year 2016 Results Read more about ICON Reports Fourth Quarter and Full Year 2016 Results
ICON Issues Financial Guidance for Full Year 2017 Read more about ICON Issues Financial Guidance for Full Year 2017
ICON Further Enhances Clinical Trial Feasibility, Protocol Optimisation and Patient Recruitment Capabilities with TriNetX Read more about ICON Further Enhances Clinical Trial Feasibility, Protocol Optimisation and Patient Recruitment Capabilities with TriNetX
ICON Announces Appointment of Mr. Ronan Murphy to Board of Directors Read more about ICON Announces Appointment of Mr. Ronan Murphy to Board of Directors
ICON Announces Executive Leadership Transition Read more about ICON Announces Executive Leadership Transition
ICON Completes the Acquisition of Clinical Research Management, Inc. Read more about ICON Completes the Acquisition of Clinical Research Management, Inc.
